Magnetic resonance imaging studies on gadonanotube‐reinforced biodegradable polymer nanocomposites
Source abstract
Abstract
Abstract We report about the in vitro cytotoxicity and MRI studies of Gd3+ions‐doped ultra‐short single‐walled carbon nanotube (gadonanotubes), gadonanotubes‐ reinforced poly(lactic‐co‐glycolic acid) (PLGA) polymer nanocomposites and in vivo small animal MRI studies using the gadonanotubes. These studies were performed to explore the suitability of gadonanotubes‐reinforced PLGA polymer nanocomposite as a model scaffold for noninvasive magnetic resonance imaging (MRI) to evaluate nanotube release during the degradation process of the scaffold and their biodistribution upon release from the polymer matrix in vivo. The gadonanotubes at 1–100 ppm and the gadonanotubes/PLGA nanocomposites (2 wt % gadonanotubes) did not show any cytotoxicity in vitro as demonstrated using the LIVE/DEAD viability assay. For the first time, r2 relaxivity measurements were obtained for the superparamagnetic gadonanotubes. In vitro 7T MRI of the superparamagnetic gadonanotubes ([Gd] = 0.15 mM) suspended in a biocompatible 1% Pluronic F127 solution, gave a r2 value of 578 mM−1 s−1. Upon subcutaneous injection of the gadonanotubes suspension into the dorsal region of rats, the high r2 value translated into excellent and prolonged negative contrast enhancement of in vivo T2weighted proton MRI images. The in vitro characterization of the nanocomposite discs and their degradation process by MRI, showed strong influence of the gadonanotube on water proton relaxations. These results indicate that the gadonanotubes/PLGA nanocomposites are suitable for further in vivo studies to track by MRI the biodegradation release and biodistribution of gadonanotubes. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res, 2010
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Polymer Nanocomposite Synthesis and Irradiation · Graphene and Nanomaterials Applications · Conducting polymers and applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (42)
Show source-provided references
1. 10.1038/nrd98810.1038/nrd988 ↗
2. 10.1002/(SICI)1521-4095(200005)12:10<750::AID-ADMA750>3.0.CO;2-610.1002/(SICI)1521-4095(200005)12:10<750::AID-ADMA750>3.0.CO;2-6 ↗
3. 10.1021/cr050569o10.1021/cr050569o ↗
4. 10.1088/0957-4484/16/7/03010.1088/0957-4484/16/7/030 ↗
5. 10.1021/bm060391v10.1021/bm060391v ↗
6. 10.1163/15685620778103413310.1163/156856207781034133 ↗
7. 10.1016/j.biomaterials.2007.05.03310.1016/j.biomaterials.2007.05.033 ↗
8. 10.1002/jbm.a.3167110.1002/jbm.a.31671 ↗
9. 10.1016/j.bone.2008.04.01310.1016/j.bone.2008.04.013 ↗
10. Pathology of the bone‐implant interfaces
11. 10.2106/00004623-200004000-0000210.2106/00004623-200004000-00002 ↗
12. 10.1016/S0142-9612(01)00374-X10.1016/S0142-9612(01)00374-X ↗
13. 10.1016/S0142-9612(03)00537-410.1016/S0142-9612(03)00537-4 ↗
14. 10.1039/b504435a10.1039/b504435a ↗
15. Gadonanotubes as new high‐performance MRI contrast agents
16. 10.1021/nl072040810.1021/nl0720408 ↗
17. 10.1021/nl02567510.1021/nl025675 ↗
18. 10.1088/0957-4484/17/20/00110.1088/0957-4484/17/20/001 ↗
19. 10.1021/bm030056w10.1021/bm030056w ↗
20. 10.1007/s10334-004-0068-210.1007/s10334-004-0068-2 ↗
21. 10.1016/j.mri.2005.12.00310.1016/j.mri.2005.12.003 ↗
22. 10.1016/0168-3659(86)90001-510.1016/0168-3659(86)90001-5 ↗
23. 10.1016/S0168-3659(97)00052-710.1016/S0168-3659(97)00052-7 ↗
24. 10.1016/S0169-409X(97)00048-310.1016/S0169-409X(97)00048-3 ↗
25. 10.1016/0168-3659(95)00061-C10.1016/0168-3659(95)00061-C ↗
26. Von Recum A · 1999
27. 10.1021/nl060177c10.1021/nl060177c ↗
28. 10.1021/nl072509z10.1021/nl072509z ↗
29. 10.1002/nbm.90410.1002/nbm.904 ↗
30. 10.1016/S1461-5347(98)00008-X10.1016/S1461-5347(98)00008-X ↗
31. 10.1016/j.addr.2005.01.02410.1016/j.addr.2005.01.024 ↗
32. 10.1016/S0168-3659(99)00260-610.1016/S0168-3659(99)00260-6 ↗
33. 10.1021/bm015621e10.1021/bm015621e ↗
34. 10.1023/A:102322322040910.1023/A:1023223220409 ↗
35. 10.1016/S0378-5173(99)00233-110.1016/S0378-5173(99)00233-1 ↗
36. 10.1023/A:101886432240010.1023/A:1018864322400 ↗
37. 10.1016/S0378-5173(01)00718-910.1016/S0378-5173(01)00718-9 ↗
38. 10.1002/(SICI)1099-1492(199904)12:2<69::AID-NBM548>3.0.CO;2-D10.1002/(SICI)1099-1492(199904)12:2<69::AID-NBM548>3.0.CO;2-D ↗
39. 10.1002/jcb.1044310.1002/jcb.10443 ↗
40. 10.1002/mrm.2007410.1002/mrm.20074 ↗
41. 10.1158/0008-5472.CAN-03-057610.1158/0008-5472.CAN-03-0576 ↗
42. 10.1158/0008-5472.CAN-03-363110.1158/0008-5472.CAN-03-3631 ↗